<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.neurologylive.com/view/levetiracetam-misses-primary-endpoint-early-alzheimer-trial</loc>
      <lastmod>2026-11-18T20:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>NeurologyLive - Clinical Neurology News and Neurology Expert Insights</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Levetiracetam Misses Primary Endpoint in Early Alzheimer Trial]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/infarct-size-alone-predict-thrombectomy-outcomes-registry-shows</loc>
      <lastmod>2026-11-18T19:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>NeurologyLive - Clinical Neurology News and Neurology Expert Insights</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T19:00:00Z</news:publication_date>
        <news:title><![CDATA[Infarct Size Alone Doesn't Predict Thrombectomy Outcomes, Registry Shows]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/mevidalen-misses-primary-endpoint-phase-2-alzheimer-trial</loc>
      <lastmod>2026-11-18T16:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>NeurologyLive - Clinical Neurology News and Neurology Expert Insights</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T16:00:00Z</news:publication_date>
        <news:title><![CDATA[Mevidalen Misses Primary Endpoint in Phase 2 Alzheimer Trial]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/beyond-relapses-and-mri-practical-ways-to-monitor-ms-control</loc>
      <lastmod>2026-11-18T13:05:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>NeurologyLive - Clinical Neurology News and Neurology Expert Insights</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T13:05:00Z</news:publication_date>
        <news:title><![CDATA[Beyond Relapses and MRI: Practical Ways to Monitor MS Control]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/positioning-b-cell-depleting-therapies-in-the-mg-treatment-sequence</loc>
      <lastmod>2026-11-18T13:05:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>NeurologyLive - Clinical Neurology News and Neurology Expert Insights</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T13:05:00Z</news:publication_date>
        <news:title><![CDATA[Positioning B-Cell–Depleting Therapies in the MG Treatment Sequence]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/pira-in-ms-recognizing-progression-independent-of-relapse-activity</loc>
      <lastmod>2026-11-18T13:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>NeurologyLive - Clinical Neurology News and Neurology Expert Insights</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T13:00:00Z</news:publication_date>
        <news:title><![CDATA[PIRA in MS: Recognizing Progression Independent of Relapse Activity]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/switching-within-or-across-drug-classes-safely-in-mg</loc>
      <lastmod>2026-11-18T13:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>NeurologyLive - Clinical Neurology News and Neurology Expert Insights</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Switching Within or Across Drug Classes Safely in MG]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/orlando-forum-weighs-dual-antiplatelet-therapy-duration-after-stroke</loc>
      <lastmod>2026-11-18T13:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>NeurologyLive - Clinical Neurology News and Neurology Expert Insights</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Orlando Forum Weighs Dual Antiplatelet Therapy Duration After Stroke]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/neurovoices-brian-lin-fda-approval-gefurulimab-generalized-mg</loc>
      <lastmod>2026-11-18T11:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>NeurologyLive - Clinical Neurology News and Neurology Expert Insights</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T11:00:00Z</news:publication_date>
        <news:title><![CDATA[NeuroVoices: Brian Lin, PhD, on the FDA Approval of Gefurulimab for Generalized Myasthenia Gravis]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/ar1001-slows-decline-monotherapy-group-phase-3-alzheimer-trial</loc>
      <lastmod>2026-11-17T22:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>NeurologyLive - Clinical Neurology News and Neurology Expert Insights</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T22:00:00Z</news:publication_date>
        <news:title><![CDATA[AR1001 Slows Decline in Monotherapy Group of Phase 3 Alzheimer Trial]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/fda-approves-adrabetadex-first-therapy-improve-survival-infantile-onset-niemann-pick-disease-type-c</loc>
      <lastmod>2026-11-17T20:08:33.448Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>NeurologyLive - Clinical Neurology News and Neurology Expert Insights</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T20:08:33.448Z</news:publication_date>
        <news:title><![CDATA[FDA Approves Adrabetadex as First Therapy Shown to Improve Survival in Infantile-Onset Niemann-Pick Disease Type C]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/full-x-tole2-data-detail-azetukalner-dose-dependent-profile-focal-epilepsy</loc>
      <lastmod>2026-11-17T20:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>NeurologyLive - Clinical Neurology News and Neurology Expert Insights</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Full X-TOLE2 Data Detail Azetukalner's Dose-Dependent Profile in Focal Epilepsy]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/spectris-misses-primary-end-point-pivotal-hope-trial-alzheimer-disease</loc>
      <lastmod>2026-11-17T18:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>NeurologyLive - Clinical Neurology News and Neurology Expert Insights</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T18:00:00Z</news:publication_date>
        <news:title><![CDATA[Spectris Misses Primary End Point in Pivotal HOPE Trial for Alzheimer Disease]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/navigating-new-era-neuromuscular-drug-development-care-mda-2027</loc>
      <lastmod>2026-11-17T16:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>NeurologyLive - Clinical Neurology News and Neurology Expert Insights</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T16:00:00Z</news:publication_date>
        <news:title><![CDATA[Navigating a New Era of Neuromuscular Drug Development and Care at MDA 2027]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/trial-enrollment-complete-pivotal-phase-2-3-study-cb03-154-als</loc>
      <lastmod>2026-11-16T14:00:00.000Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>NeurologyLive - Clinical Neurology News and Neurology Expert Insights</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Trial Enrollment Complete for Pivotal Phase 2/3 Study of CB03-154 in ALS]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/roche-launches-phase-2-tarbela-ad-trial-nlrp3-inhibitor-alzheimer-disease</loc>
      <lastmod>2026-11-17T11:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>NeurologyLive - Clinical Neurology News and Neurology Expert Insights</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-17T11:00:00Z</news:publication_date>
        <news:title><![CDATA[Roche Launches Phase 2 TARBELA-AD Trial of NLRP3 Inhibitor in Alzheimer Disease]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.neurologylive.com/view/benjamin-greenberg-highlights-from-2026-rare-neuroimmune-disorders-symposium</loc>
      <lastmod>2026-11-16T23:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>NeurologyLive - Clinical Neurology News and Neurology Expert Insights</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-16T23:00:00Z</news:publication_date>
        <news:title><![CDATA[Benjamin Greenberg, MD, MHS, on Highlights From the 2026 Rare Neuroimmune Disorders Symposium]]></news:title>
      </news:news>
	</url></urlset>